NUTRA PHARMA CORP
NPHC · OTCMCIK 1119643fmd_0VBWQ6Y0GR3F7TKRY3ES0DKN1K制造业 · 医药化学品及植物药模板: 标准
覆盖范围: 2009年1月01日 至 2026年6月30日，共 66 个期间
| 项目 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 营业成本 | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 | 0 |
| 净利息收入 | – | – | 0 | – | – | – | – | – | – | – |
| 毛利润 | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 信用损失准备 | – | – | – | – | – | – | – | – | – | – |
| 研发费用 | – | – | – | – | – | – | – | – | – | – |
| 销售、一般及管理费用 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | – |
| 营业费用合计 | – | – | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 2 |
| 薪酬与福利 | – | – | – | – | – | – | – | – | 1 | 1 |
| 营业利润 | (2) | (1) | (2) | (1) | (1) | (2) | (2) | (1) | (1) | (1) |
| 利息费用 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 其他营业外收入（支出） | – | – | (2) | (5) | 0 | (11) | 10 | (1) | (0) | (1) |
| 税前利润 | (3) | (4) | (4) | (7) | (1) | (13) | 8 | (1) | (1) | (2) |
| 所得税费用 | – | – | – | – | – | – | – | – | – | – |
| 持续经营净利润 | – | – | – | – | – | – | – | – | – | – |
| 净利润 | (3) | (4) | (4) | (7) | (1) | (13) | 8 | (1) | (1) | (2) |